Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06582056 · ClinicalTrials.gov registry record · NA
Study on Biomarkers of Periodontitis and Type 2 Diabetes Mellitus in Males and Females 30 - 70 Years of Age
A NA study, sponsored by Sanofi Pasteur, a Sanofi Company.
- Completed
- Registry status
- NA
- Development phase
- 226
- Enrollment target
NCT06582056 is a NA study that has completed, run by Sanofi Pasteur, a Sanofi Company. The registered enrollment target is 226 participants.
The verdict
NCT06582056, a NA study, has completed, sponsored by Sanofi Pasteur, a Sanofi Company.
- COMPLETED
- Registry status
- NA
- Development phase
- 226 participants
- Enrollment target
Study Summary
The purpose of this study is to learn about the interactions of markers of type 2 diabetes (T2DM) and periodontitis (PD). Study VPE00001 is a multi-center cross-sectional study. Participants will be categorized based on point-of-care hemoglobin A1c (HbA1c) and periodontal disease (PD) staging into 9 subgroups. The key objectives of the study are: * To evaluate immune signatures in well-characterized populations with or without PD and/or T2DM * To evaluate baseline clinical biomarkers of T2DM and PD in well-characterized populations * To evaluate the influence of clinical, immunological, and microbiological biomarkers on the bidirectional relationship between T2DM and PD
Interventions
- PROCEDURE Investigational Procedure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 226 participants |
| Start Date | 2024-10-09 |
| Est. Completion | 2025-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06582056
The ClinicalTrials.gov registry entry for NCT06582056 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 226 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sanofi Pasteur, a Sanofi Company, which has 153 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Investigational Procedure is the first listed.
NCT06582056 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06582056 about?
NCT06582056 is a clinical study titled "Study on Biomarkers of Periodontitis and Type 2 Diabetes Mellitus in Males and Females 30 - 70 Years of Age". The purpose of this study is to learn about the interactions of markers of type 2 diabetes (T2DM) and periodontitis (PD). Study VPE00001 is a multi-center cross-sectional study. Participants will be categorized based on point-of-care hemoglobin A1c (HbA1c) and periodontal disease (PD) staging into 9...
What is the current status of trial NCT06582056?
This trial is currently completed. It is a NA study. The enrollment target is 226 participants. The study started on 2024-10-09. Estimated completion is 2025-09-30.
What interventions are being tested in trial NCT06582056?
The interventions under investigation include: Investigational Procedure (PROCEDURE).
Who is sponsoring clinical trial NCT06582056?
This trial is sponsored by Sanofi Pasteur, a Sanofi Company, which has 153 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.